Mass General Brigham study shows US obesity could jump from 40% to 70%
The prevalence of obesity in the United States could rise sharply under a new definition of obesity released…
Purespring Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
Purespring Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference London – 14 October 2025 – Purespring…
AI-designed proteins revolutionize gene editing precision and safety
Researchers at Integra Therapeutics, in collaboration with the Pompeu Fabra University (UPF) Department of Medicine and Life Sciences…
Study reveals a new oncogenic role of NBL1 in ovarian cancer metastasis
Ovarian cancer (OC), one of the three most common gynecological malignancies, is characterized by low early detection rates…
Enhanced Genomics extends Series A funding to USD $19 million to drive development of therapeutics pipeline
Sep 17 2025 Enhanced Genomics (‘Enhanced’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated…
Mentavi study validates first fully digital diagnostic pathway for adult ADHD
Mentavi Health announced that its landmark, real-world validation study of the Mentavi Diagnostic Evaluation has been published in…
Study identifies C1orf122 as prognostic marker in liver cancer
Primary liver cancer is the third leading cause of cancer-related deaths, of which hepatocellular carcinoma (HCC) accounts for…
RAB26 identified as a critical regulator of prostate cancer aggressiveness
Prostate cancer (PCa) is one of the most common malignant tumors in men worldwide. While early detection has…